Understanding How Hepatitis C Affects Mortality
Author Information
Author(s): Yi-Ting Huang, Yao-Chun Hsu, Hwai-I Yang, Mei-Hsuan Lee, Chien-Jen Chen, Yen-Tsung Huang
Primary Institution: Academia Sinica
Hypothesis
What is the role of intrahepatic and extrahepatic diseases in mediating HCV-induced mortality?
Conclusion
Both intrahepatic and extrahepatic manifestations mediated approximately half of HCV-induced mortality.
Supporting Evidence
- 54.1% of HCV-induced mortality was mediated by intrahepatic diseases.
- 45.9% of mortality was mediated by extrahepatic diseases.
- Septicemia was a major extrahepatic mediator with a 25.2% contribution to HCV-induced mortality.
Takeaway
Hepatitis C can make people sick in different ways, and both liver problems and other diseases can lead to death from it.
Methodology
A community-based cohort study with over 25 years of follow-up was conducted, linking cohort data to Taiwan’s National Health Insurance Research Database.
Potential Biases
Potential misclassification of disease status may lead to an underestimation of mediation effects.
Limitations
The study only included diseases with a prevalence between 10% and 90%, which may exclude rare diseases.
Participant Demographics
The cohort included 18,972 participants, with 934 being HCV carriers, generally older, more women, and with higher ALT levels.
Statistical Information
Confidence Interval
95% CI, 1.22–1.41
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website